JP2009522377A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009522377A5 JP2009522377A5 JP2008549685A JP2008549685A JP2009522377A5 JP 2009522377 A5 JP2009522377 A5 JP 2009522377A5 JP 2008549685 A JP2008549685 A JP 2008549685A JP 2008549685 A JP2008549685 A JP 2008549685A JP 2009522377 A5 JP2009522377 A5 JP 2009522377A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cancer
- unsubstituted
- pharmaceutically acceptable
- acceptable salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 39
- 230000003287 optical effect Effects 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 4
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims 4
- OESHPIGALOBJLM-REOHCLBHSA-N dehydroascorbate Chemical compound OC[C@H](O)[C-]1OC(=O)C(=O)C1=O OESHPIGALOBJLM-REOHCLBHSA-N 0.000 claims 4
- 235000020960 dehydroascorbic acid Nutrition 0.000 claims 4
- 239000011615 dehydroascorbic acid Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 2
- 208000023105 Huntington disease Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 206010040047 Sepsis Diseases 0.000 claims 2
- 208000000277 Splenic Neoplasms Diseases 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 2
- 206010057644 Testis cancer Diseases 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000004101 esophageal cancer Diseases 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 201000010453 lymph node cancer Diseases 0.000 claims 2
- 208000002780 macular degeneration Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 201000002314 small intestine cancer Diseases 0.000 claims 2
- 201000002471 spleen cancer Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 201000003120 testicular cancer Diseases 0.000 claims 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 claims 1
- 208000024714 major depressive disease Diseases 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75725206P | 2006-01-09 | 2006-01-09 | |
| US60/757,252 | 2006-01-09 | ||
| US78179406P | 2006-03-13 | 2006-03-13 | |
| US60/781,794 | 2006-03-13 | ||
| US80414906P | 2006-06-07 | 2006-06-07 | |
| US60/804,149 | 2006-06-07 | ||
| PCT/US2007/060277 WO2007082208A2 (en) | 2006-01-09 | 2007-01-09 | Lanthionine-related compounds for the treatment of inflammatory diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009522377A JP2009522377A (ja) | 2009-06-11 |
| JP2009522377A5 true JP2009522377A5 (enExample) | 2010-02-25 |
| JP5367377B2 JP5367377B2 (ja) | 2013-12-11 |
Family
ID=38051848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008549685A Expired - Fee Related JP5367377B2 (ja) | 2006-01-09 | 2007-01-09 | 炎症性疾患治療のためのランチオニン関連化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7683055B2 (enExample) |
| EP (1) | EP1981862B1 (enExample) |
| JP (1) | JP5367377B2 (enExample) |
| AT (1) | ATE500236T1 (enExample) |
| AU (1) | AU2007204757B2 (enExample) |
| CA (1) | CA2636042C (enExample) |
| DE (1) | DE602007012833D1 (enExample) |
| DK (1) | DK1981862T3 (enExample) |
| PT (1) | PT1981862E (enExample) |
| WO (1) | WO2007082208A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305834A1 (en) * | 2009-10-02 | 2011-04-06 | Advanced Practical Diagnostics N.V. | Haplotype of KATIII gene |
| EP2524925B1 (en) * | 2009-12-28 | 2016-08-17 | Ajinomoto Co., Inc. | Lanthionine derivative |
| WO2011140215A2 (en) * | 2010-05-04 | 2011-11-10 | Virginia Tech Intellectual Properties, Inc. | Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders |
| WO2012027455A1 (en) * | 2010-08-24 | 2012-03-01 | The University Of Toledo | Glutathione-lanthionine compounds and methods related thereto |
| CN102670796A (zh) * | 2012-05-22 | 2012-09-19 | 广西天天乐药业股份有限公司 | 一种治疗脾胃虚弱的中药及其制备方法 |
| JP2017141497A (ja) * | 2016-02-12 | 2017-08-17 | 二村 芳弘 | エラスチン増加作用を呈するメチルランチオニン誘導体の製造方法 |
| US11084836B2 (en) * | 2016-02-26 | 2021-08-10 | The University Of Toledo | Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same |
| US10882831B2 (en) * | 2017-02-23 | 2021-01-05 | The University Of Toledo | Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2283186A (en) * | 1942-05-19 | Thiazane-j | ||
| US6025395A (en) * | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| MXPA03006321A (es) * | 2001-01-16 | 2003-10-06 | Genset Sa | Tratamiento de trastornos del sistema nervioso central usando antagonistas de d-aminoacido oxidasa y d-aspartato oxidasa. |
| US20030166554A1 (en) * | 2001-01-16 | 2003-09-04 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| US20030185754A1 (en) * | 2001-01-16 | 2003-10-02 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
-
2007
- 2007-01-09 DE DE602007012833T patent/DE602007012833D1/de active Active
- 2007-01-09 US US11/621,469 patent/US7683055B2/en not_active Expired - Fee Related
- 2007-01-09 AT AT07710015T patent/ATE500236T1/de active
- 2007-01-09 WO PCT/US2007/060277 patent/WO2007082208A2/en not_active Ceased
- 2007-01-09 EP EP07710015A patent/EP1981862B1/en not_active Not-in-force
- 2007-01-09 DK DK07710015.4T patent/DK1981862T3/da active
- 2007-01-09 PT PT07710015T patent/PT1981862E/pt unknown
- 2007-01-09 AU AU2007204757A patent/AU2007204757B2/en not_active Ceased
- 2007-01-09 JP JP2008549685A patent/JP5367377B2/ja not_active Expired - Fee Related
- 2007-01-09 CA CA2636042A patent/CA2636042C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009522377A5 (enExample) | ||
| JP2014520823A5 (enExample) | ||
| US10280183B2 (en) | Therapeutic agent for treating tumors | |
| WO2017087428A1 (en) | (r)- and (s)-1-(3-(3-n,n-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-n,n'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation | |
| JP2009530399A5 (enExample) | ||
| RU2013156687A (ru) | Антагонисты рецептора св1 | |
| JP2013520502A5 (enExample) | ||
| US10409869B2 (en) | (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation | |
| CA2769553A1 (en) | Novel pyrimidine and triazine hepcidin antagonists | |
| JP2015517579A5 (enExample) | ||
| CU20100118A7 (es) | Compuestos orgánicos | |
| JP2017538773A5 (enExample) | ||
| ES2843798T3 (es) | Conjugados y profármacos para el tratamiento del cáncer y de enfermedades inflamatorias | |
| JP2010511626A5 (enExample) | ||
| JP2016519062A5 (enExample) | ||
| UY33605A (es) | Profarmacos que comprenden un conjugado de conector de exendina | |
| HRP20160249T1 (hr) | Pirolidinoni kao inhibitori metap2 | |
| JP2009536191A5 (enExample) | ||
| CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| JP2008543860A5 (enExample) | ||
| RU2007146669A (ru) | Пролекарства антагонистов a2b рецептора аденозина | |
| JP2009502777A5 (enExample) | ||
| JP2007532649A5 (enExample) | ||
| JP2009502775A5 (enExample) | ||
| JP2013537228A5 (enExample) |